Cover Image

Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration

Nowadays; intravitreal anti-vascular endothelial growth factor (VEGF) drugs are considered the first-line therapeutic strategy for treating macular exudative diseases; including wet age-related macular degeneration (w-AMD) and diabetic macular edema (DME). Despite the important clinical achievements...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lorenzo Ferro Desideri (Author), Carlo Enrico Traverso (Author), Massimo Nicolò (Author), Marion R. Munk (Author)
Format:	Book
Published:	MDPI AG, 2023-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

First-Year Real-Life Experience with Intravitreal Faricimab for Refractory Neovascular Age-Related Macular Degeneration
by: Wissam Aljundi, et al.
Published: (2024)

Conbercept for Treatment of Neovascular Age-Related Macular Degeneration and Visual Impairment due to Diabetic Macular Edema or Pathologic Myopia Choroidal Neovascularization: A Systematic Review and Meta-Analysis
by: Pengxiang Zhou, et al.
Published: (2021)

Spotlight on Faricimab in the Treatment of Wet Age-Related Macular Degeneration: Design, Development and Place in Therapy
by: Nair AA, et al.
Published: (2022)

EFEMP1 Overexpression Contributes to Neovascularization in Age-Related Macular Degeneration
by: Lu Cheng, et al.
Published: (2021)

Profile of conbercept in the treatment of neovascular age-related macular degeneration
by: Lu XM, et al.
Published: (2015)

Current and Future Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
by: Kaiser SM, et al.
Published: (2021)

Synthetic anti-angiogenic genomic therapeutics for treatment of neovascular age-related macular degeneration
by: Jing Wang, et al.
Published: (2021)

Edema macular cistoideo Macular cystoid edema
by: Blanca Nieve Rey Estévez, et al.
Published: (2010)

Age-Related Macular Degeneration and Diabetic Retinopathy
Published: (2022)

Clinical effectiveness of ranibizumab and conbercept for neovascular age-related macular degeneration: a meta-analysis
by: Wang LP, et al.
Published: (2018)

Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review
by: Yang S, et al.
Published: (2016)

Identifying subtypes of patients with neovascular age-related macular degeneration by genotypic and cardiovascular risk characteristics
by: Kim Ivana K, et al.
Published: (2011)

Application of Artificial Intelligence Models to Predict the Onset or Recurrence of Neovascular Age-Related Macular Degeneration
by: Francesco Saverio Sorrentino, et al.
Published: (2024)

Cytokine and Chemokine Profile Changes in Patients with Neovascular Age-Related Macular Degeneration After Intravitreal Ranibizumab Injection for Choroidal Neovascularization
by: Sun T, et al.
Published: (2021)

Hypertensive disorders of pregnancy increase the risk of developing neovascular age-related macular degeneration in later life
by: Karen Curtin, et al.
Published: (2019)

Vascular Endothelial Growth Factor Antagonists: Promising Players in the Treatment of Neovascular Age-Related Macular Degeneration
by: Hussain RM, et al.
Published: (2021)

Nanotechnology for Age-Related Macular Degeneration
by: Bo Yang, et al.
Published: (2021)

Mechanism of Inflammation in Age-Related Macular Degeneration
by: Francesco Parmeggiani, et al.
Published: (2012)

Health-related quality of life in patients with neovascular age-related macular degeneration: a prospective cohort study
by: Anna-Maria Kubin, et al.
Published: (2024)

Faricimab: Transforming the Future of Macular Diseases Treatment - A Comprehensive Review of Clinical Studies
by: Panos GD, et al.
Published: (2023)

First Year Real Life Experience With Intravitreal Brolucizumab for Treatment of Refractory Neovascular Age-Related Macular Degeneration
by: Alaa Din Abdin, et al.
Published: (2022)

Metabolomics study of treatment response to conbercept of patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
by: Yinchen Shen, et al.
Published: (2022)

Evaluation of cardiac parameters and other safety outcomes of brolucizumab treatment in patients with neovascular age‐related macular degeneration
by: Nadia Zakaria, et al.
Published: (2022)

Preliminary in vitro and in vivo assessment of a new targeted inhibitor for choroidal neovascularization in age-related macular degeneration
by: Li W, et al.
Published: (2016)

The Short-term efficacy of a monoclonal antibody fragment (brolucizumab) for treating neovascular age-related macular degeneration
by: A. F. Yusupov, et al.
Published: (2024)

Global prevalence of age-related macular degeneration
by: Jost B Jonas
Published: (2014)

Age-Related Macular Degeneration Etiology, Diagnosis and Management - A Glance at the Future
Published: (2013)

Age Related Macular Degeneration The Recent Advances in Basic Research and Clinical Care
Published: (2012)

Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy
by: Nicola Ferrante, et al.
Published: (2022)

Evaluation of Aqueous Flare Intensity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular Age-Related Macular Degeneration
by: Joanna Dolar-Szczasny, et al.
Published: (2021)

The influence of delayed treatment due to COVID-19 on patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
by: Xinyu Zhao, et al.
Published: (2021)

Molecular Biomarkers of Neovascular Age-Related Macular Degeneration With Incomplete Response to Anti-Vascular Endothelial Growth Factor Treatment
by: Irmela Mantel, et al.
Published: (2020)

Prevention of macular edema and secondary degeneration of the macula and posterior pole in anterior uveitis
by: N.V. Konovalova, et al.
Published: (2019)

The role of aflibercept in the management of diabetic macular edema
by: Chang AA, et al.
Published: (2015)

Some considerations about the diabetic macular edema
by: Blanca Nieve Rey Estevez, et al.
Published: (2017)

The Evolving Treatment Options for Diabetic Macular Edema
by: Atul Jain, et al.
Published: (2013)

Mingjing granule inhibits the subretinal fibrovascular membrane of two-stage laser-induced neovascular age-related macular degeneration in rats
by: Xiaoyu Li, et al.
Published: (2024)

The NEI/NCBI dbGAP database: Genotypes and haplotypes that may specifically predispose to risk of neovascular age-related macular degeneration
by: Miller Joan W, et al.
Published: (2008)

Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration
by: Jose Navarro-Partida, et al.
Published: (2021)

Diagnosis, Treatment and Prevention of Age-Related Macular Degeneration
Published: (2022)